Doehn, C <br/><br/>
[Immunotherapy of renal cell carcinoma: results from current phase-III-trials].  [electronic resource] 

 -  Aktuelle Urologie  Apr 2004 
 - 121-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0001-7868 
<br/><br/><label>Standard No.: </label>10.1055/s-2004-818414  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cancer Vaccines--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>Combined Modality Therapy<br/>Cytokines--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Immunotherapy<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Interferon-gamma--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Kidney--pathology<br/>Kidney Neoplasms--drug therapy<br/>Neoplasm Staging<br/>Nephrectomy<br/>Recombinant Proteins<br/>Time Factors